Engineering ROS-scavenging Prussian blue nanozymes for efficient atherosclerosis nanotherapy
Author:
Affiliation:
1. Department of Ultrasound, Shanghai East Hospital, Tongji University, Shanghai 200120, P. R. China
2. Materdicine Lab, School of Life Sciences, Shanghai University, Shanghai 200444, P. R. China
Abstract
Funder
National Natural Science Foundation of China
Shanghai Municipal Health Commission
Publisher
Royal Society of Chemistry (RSC)
Subject
General Materials Science,Biomedical Engineering,General Chemistry,General Medicine
Link
http://pubs.rsc.org/en/content/articlepdf/2023/TB/D2TB02661A
Reference51 articles.
1. Inflammatory endothelium-targeted and cathepsin responsive nanoparticles are effective against atherosclerosis
2. Atherosclerosis: Recent developments
3. Targeting inflammation in atherosclerosis — from experimental insights to the clinic
4. Inflammation in Atherosclerosis—No Longer a Theory
5. Oxidative Stress and Inflammation, Key Targets of Atherosclerotic Plaque Progression and Vulnerability: Potential Impact of Physical Activity
Cited by 8 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Nanozyme-enhanced mitophagy to improve the efficacy of mesenchymal stem cells in myocardial infarction therapy;Applied Materials Today;2024-08
2. Prussian Blue Nanoparticle: From a Photothermal Conversion Agent and a Drug Delivery System, to a Bioactive Drug;Accounts of Materials Research;2024-04-05
3. β-Cyclodextrin-based nanoassemblies for the treatment of atherosclerosis;Regenerative Biomaterials;2024
4. Functional nanostructured materials and processes: an introduction;Pulsed Laser-Induced Nanostructures in Liquids for Energy and Environmental Applications;2024
5. Emerging drug delivery systems with traditional routes – A roadmap to chronic inflammatory diseases;Advanced Drug Delivery Reviews;2023-12
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3